Detalhe da pesquisa
1.
Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus.
Antimicrob Agents Chemother
; 64(9)2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631823
2.
Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
J Virol
; 93(6)2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626682
3.
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
Sci Transl Med
; 15(716): eadg3540, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792954
4.
A serological assay to detect SARS-CoV-2 seroconversion in humans.
medRxiv
; 2020 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511441
5.
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
Vaccine
; 37(37): 5567-5577, 2019 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399277
6.
An HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model.
Vaccines (Basel)
; 7(2)2019 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31137559
7.
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.
Front Immunol
; 10: 2005, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31497029
8.
Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus?
Curr Opin Immunol
; 53: 45-50, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29677684